SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 116,000
-3,500 (-2.93%)
Nov 7, 2025, 3:30 PM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 9.08 trillion as of November 7, 2025. Its market cap has decreased by -1.53% in one year.
Market Cap
9.08T
Enterprise Value
8.96T
Revenue
620.28B
Ranking
n/a
PE Ratio
35.49
Stock Price
116,000.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 9.08T, a decrease of -8.66%. That is a compound annual growth rate of -1.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 9.08T | 4.41% |
| Dec 30, 2024 | 8.70T | 10.66% |
| Dec 28, 2023 | 7.86T | 39.25% |
| Dec 29, 2022 | 5.65T | -25.82% |
| Dec 30, 2021 | 7.61T | -42.49% |
| Dec 30, 2020 | 13.23T | 33.07% |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.53T |
| ALTEOGEN | 28.29T |
| Yuhan | 8.71T |
| HLB Co., Ltd. | 7.14T |
| Peptron | 6.11T |
| Hanmi Pharm. | 5.82T |
| ABL Bio | 5.72T |